Schering-Plough Corporation was a United States-based pharmaceutical company. It was founded in 1851 by Ernst Christian Friedrich Schering as Schering AG in Germany. In 1971, the Schering Corporation merged with Plough (founded by Memphis area entrepreneur Abe Plough in 1908 ) to form Schering-Plough. On November 4, 2009 Merck & Co. was merged with Schering-Plough with the new company taking the name of Merck & Co.
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
Latest FEC Datacovers through committee's April 5, 2010 filing.
Summaryoverview of the committee's finances
- Total Raised:
- Total Spent:
- Cash on Hand:
Standardized Donation Informationcovers roughly through Q3 2013. may lag behind FEC section above, as donors and industries are identified by hand.
- Employee Color Block
- PAC Color Block
Republicans vs. Democratsin dollars. "Other" includes 3rd parties and organizations without official party affiliation.
State vs. Federalin dollars
Top PAC Recipients
- Employee Color Block
- PAC Color Block
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Schering-Plough Corp
Names of Lobbyists
Firm Hired Amount Schering-Plough Corp $1,810,000 Ruder Finn Inc $0
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Medicare & Medicaid,
- Copyright, Patent & Trademark,
- Labor, Antitrust & Workplace,
- Foreign Relations,
- Fed Budget & Appropriations
Most Frequently Disclosed Bills
Bill No. Title H.R.2 Children's Health Insurance Program Reauthorization Act of 2009 H.R.1 American Recovery and Reinvestment Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 H.R.1260 Patent Reform Act of 2009 H.R.1298 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act S.260 S.369 Preserve Access to Affordable Generics Act S.515 Patent Reform Act of 2009
RegulationsMentioned in 168 dockets; Submitted to 10 dockets
All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "Schering-Plough Corp" in public comments on proposed federal regulations.
Documents Submitted by the Organization
View all submissions data for Schering-Plough Corp
- Toggle 1 HHS Meaningful use of Healthcare Information Technology 2009
- Toggle 1 PHMSA Schering-Plough - Permit to Transport Hazardous Materials 2009
- Toggle 1 NOAA Notification of Receipt of a Petition for Rulemaking to Implement the Provisions of the Marine Mammal Protection Act for Swordfish Imports 2009
- Toggle 1 FDA Draft Guidance for Industry on the Clinical Pharmacology Section of Labeling for Human Prescription Drug and Biological Products—Content and Format; Availability 2009
- Toggle 1 FDA Draft Guidance for Industry; Incorporation of Physical-Chemical Identifiers into Solid Oral Dosage Form Drug Products for Anticounterfeiting; Availability 2009
- Toggle 1 FDA Agency Information Collection Activities; Proposed Collection; Comment Request; Importer’s Entry Notice 2009
- Toggle 1 NIH Public Meeting on Expansion of the Clinical Trial Registry and Results Data Bank 2009
- Toggle 1 FDA International Conference on Harmonisation; Draft Guidance on S9 Nonclinical Evaluation for Anticancer Pharmaceuticals; Availability. 2009
- Toggle 1 FDA Patent Term Extension Application for EOVIST® (gadoxetate disodium), U.S. Patent No. 6,039,931 2009
- Toggle 1 FDA Developing a Consolidated Pediatric Rheumatology Observational Registry; Public Workshop 2009
Mentions in Document Text
View all mentions data for Schering-Plough Corp
- Toggle 19 FDA Veterinary Feed Directive 2010
- Toggle 13 EPA Rulemaking for the Steam Electric Power Generating Effluent Limitations Guidelines 2009
- Toggle 12 FDA NADA/ANADA Notices 2009
- Toggle 8 FDA Patent Term Extension Application for EOVIST® (gadoxetate disodium), U.S. Patent No. 6,039,931 2009
- Toggle 8 FDA Specific Legal and Scientific Requirements be Upheld in the Review of Proposed Generic Copies of Inhalation Products Containing Fluticasone Propionate and/or Salmeterol Xinafoate 2009
- Toggle 5 EPA Clean Air Transport Rule 2009
- Toggle 4 FDA NADA/ANADA Notices 2010
- Toggle 4 EPA Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2010 2009
- Toggle 4 EPA National Advisory Committee for Acute Exposure Guideline Levels (AEGLs) for Hazardous Substances; Proposed AEGL Values; Notice of Availability 2009
- Toggle 3 EPA Identification of Additional Classes of Facilities for Development of Financial Respnsibility Requirements Under Section 108(b): Notice and Request for Comment 2009
Contractor Misconduct3 Instances
This information is collected by the Project On Government Oversight from press releases, court documents, news reports and other public records. It is not meant to be an exhaustive account of all instances of federal contractor misconduct.
More information on each instance, including primary source documents, is available on POGO's site by clicking on the instance description. More information on POGO's methodology is available here.
|Misconduct Type||Hired By||Incident||Year||Disposition||Penalty|
|Securities||None||Clarinex Securities Fraud Class Action||2009||Settlement||$165,000,000|
|Antitrust||None||Albuterol False Claims||2009||Settlement||$69,000,000|
|Government Contract Fraud||State/Local||Missouri Pricing Lawsuit||2010||Settlement||$31,000,000|
Advisory Committees2 people on 2 committees
Data is based on disclosures required by the Federal Advisory Committee Act (FACA). Matches are based on the occurrence of the company name in the committee member affiliation. Variations in company names may cause some matches to be missed.
The table shows only the top 10 agencies. To search and download raw records from the complete dataset see the FACA data section.
Table shows employees of "Schering-Plough Corp" that sat on federal advisory committees.
- Toggle Department of Commerce 1 person on 1 committee
- Toggle Department of Health and Human Services 1 person on 1 committee